共 50 条
- [2] Rifaximin for improving abdominal pain and bloating symptoms in patients with irritable bowel syndrome with diarrhea (IBS-D) using modified definitions of pain response [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
- [3] Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D), by Baseline Pain Severity [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S251
- [5] Characterization of abdominal pain response to rifaximin in patients with irritable bowel syndrome with diarrhea (IBS-D), by baseline (BL) pain severity [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
- [7] Impact of Colonoscopy Timing on Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S295 - S295
- [8] The Strong Association Between Bloating, Abdominal Pain, and Global Irritable Bowel Syndrome (IBS) Symptom Scores in IBS With Diarrhea (IBS-D): A Phase 3 Trial Pooled Correlation Analysis of Individual Symptoms [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S396 - S396
- [9] Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S269 - S269
- [10] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236